The lyophilization equipment and services market size is calculated at USD 8.74 billion in 2025 and is expected to reach USD 20.54 billion by 2035, expanding at a CAGR of 8.92% from 2026 to 2035, as lyophilization equipment is a promising strategy that has been broadly explored to stabilize small molecular proteins, therapeutics, proteins, and cells. The market is growing in 2026 because various lyophilization approaches enable pharmaceutical developers to stabilize formulations and therapeutic molecules via commercially validated processes. It is expected to expand through 2035 due to the fact that it provides significant benefits for stabilizing liquid drug technology, improving product shelf life, and reducing the need for costly cold-chain logistics. North America accounted for 8.31% of the market in 2025 due to the rising consumer demand for premium, natural, and preservative-free packaged foods.
Lyophilization equipment and services, known as freeze-drying, are a significant process broadly applied in healthcare manufacturing to preserve and stabilise sensitive materials. Lyophilization is a process in which water is removed from a product after it is frozen and placed under a vacuum, enabling the ice to change directly from solid to vapor, deprived of passing via a liquid phase. This process is significant for maintaining the structural integrity and effectiveness of pharmaceuticals, predominantly those sensitive to heat and moisture, like antibodies, vaccines, and other biologics. By efficiently removing water from the product under low temperatures, lyophilization ensures that the chemical and physical characteristics of the active ingredients are preserved without compromising their bioactivity.
Lyophilization is a dehydration technology that includes freezing the product, lowering pressure, and then sublimating the ice by sublimation. This technique is significant for preserving a broad range of materials, involving pharmaceuticals, biopharmaceuticals, and food products, without compromising their chemical structure, bioactivity, and potency. Lyophilization is complete; the dry product is sealed under a vacuum or in an inert gas environment to protect it from oxidation and moisture. The product is often additionally processed into forms that are significantly more convenient for storage, handling, or usage, like vialing for medications.
This technology is a significant application of healthcare, food preservation, and laboratory applications to maintain product integrity, extend shelf life, and guarantee easy reconstitution. Major opportunities of continuous processing and automation, advanced biopharmaceuticals, diagnostics and personalized medicine, hybrid and continuous systems, and tray-style freeze dryers. Recent developments in controlled ice nucleation, microwave-assisted lyophilization, automation and robotics, and sustainability and energy efficiency.
Integration of AI-driven technologies in the lyophilization industry supports visualizing highly complex, nonlinear, and dynamically changing food drying processes to fully appreciate the drying kinetics and aid in the optimization of the drying technology. AI-based technology transforms lyophilization via predictive modelling that hastens cycle advancement, adaptive technofixes control for real-time optimization, and resource-efficient digital simulations. Artificial intelligence holds enormous promise for transforming lyophilization in healthcare manufacturing. The technology allowed AI-based optimization for freeze drying and real-time cycle modification, causing to optimized drying recipes and fewer equipment failures. Applying AI to predict optimal cycle parameters and identify anomalies while freeze-drying. Recent developments in AI-driven algorithms, when integrated with EMF-assisted freeze drying, have the strength to optimize drying kinetics in real time, balance product quality with energy effectiveness, and simulate thousands of operating conditions via healthcare models.
Green Lyophilization:
Green lyophilization secures the functionality and stability of delicate materials, such as enzymes, proteins, and other biomolecules. The implementation of greener, maintainable, and energy-efficient refrigerants and cooling systems in up-to-date tools lowers environmental impact. Green lyophilization is a biodegradable strategy to freeze-drying that prioritizes energy-efficient tools, natural refrigerants, and lowered carbon footprints.
Food Industry Expansion:
Financial development and population growth are fostering inclusive food consumption, while a rising middle class is demanding advanced quality and variety, which propels the demand for lyophilization tools and services. Increasing production lowers downtime, and food that looks, tastes, and performs advances. It lyophilization efficiently protects bioactive compounds, color, flavor, and rehydration capability in different food technologies, involving vegetables, fruits, meats, specialty products, and seafood.
Smart Lyophilizers:
Smart lyophilizers, or smart freeze dryers, provide sophisticated automation, real-time monitoring, and improved cycle development, crucially reducing, often by days, the time needed for healthcare and food processing. This technology provides continuous monitoring of the ice interface and product temperature, preventing product collapse or melt-back while enhancing the duration of primary and secondary drying phases.
| Table | Scope |
| Market Size in 2026 | USD 9.52 Billion |
| Projected Market Size in 2035 | USD 20.54 Billion |
| CAGR (2026 - 2035) | 8.92% |
| Historical Data | 2020 - 2023 |
| Base Year | 2025 |
| Forecast Period | 2026 - 2035 |
| Measurable Values | USD Millions/Units/Volume |
| Market Segmentation | By Product Type, By Material, By Technology, By Application, By End User, By Region |
| Top Key Players | ATS, Azbil, Buchi, Cuddon, GEA Group Aktiengesellschaft, HOF Sonderanlagenbau |
| Segment | Share 2025 (%) |
| Equipment | 56% |
| Services | 29% |
| Accessories & Consumables | 15% |
The Equipment Segment Led the Lyophilization Equipment and Services Market in 2025
The equipment segment contributed the largest market share of 56% in 2025, as modern lyophilizers feature improved shelf temperature control, enhanced vacuum systems, and better condenser designs. These enhancements allow for significantly uniform drying and energy effectiveness. Eliminating water limits the initiators of degradation. The resultant product maintains stability for long periods at room temperature. The advanced control technology maintains optimal temperature and pressure conditions, which prevent degradation of sensitive pharmaceutical compounds during lyophilization.
The services segment held a significant share of 29% and is expected to grow at the fastest CAGR of 10.44% during the forecast period in the market, as lyophilization rapidly removes water, putting fragile reagents into stability. Lyophilized, cold storage is no longer required, and the lyophilized assay reagents are stored at ambient temperatures, therefore lowering the carbon footprint related to overnight shipping, freezer farms, and temperature-controlled substructure.
The accessories & consumables segment held a significant share of 15%, as accessories of lyophilization provide significant benefits, from enhanced sample stability and purity to enlarged shelf life and reduced expenses. Lyophilization tools offer a convenient and safe technology for long-term storage of lab samples and healthcare products while preserving their activity.
| Segment | Share 2025 (%) |
| Laboratory Scale | 24% |
| Pilot Scale | 28% |
| Commercial/Production Scale | 48% |
The Commercial/Production Scale segment led the Lyophilization Equipment and Services Market in 2025
The commercial/production scale segment contributed the largest market share of 48%, and is expected to grow at the fastest CAGR of the 9.54% during the forecast period in the market, as commercial and production-scale lyophilization offers significant advantages for biologics, vaccines, and sensitive APIs by allowing structural stabilization, increasing shelf life, and potentially lowering logistical and transportation expenses.
The pilot scale segment held a significant share of 28% of the market, as pilot technology holds 50 to 500 vials, enabling testing how formulation behaves in larger arrays deprived of risking an entire commercial run. Pilot tools utilize the same premium materials, such as 316L stainless steel and control technology, as full-scale production units, offering highly precise scale-up modeling.
The laboratory scale segment held a significant share of 24% of the market, as dehydration by lyophilization provides significant benefits, from enhanced sample stability and purity to amplified shelf life and lower expenses. As well as growing shelf life, freeze-drying samples lowers their weight and volume, supporting a cut down on shipping expenses and environmental impact.
| Segment | Share 2025 (%) |
| Manifold Freeze Drying | 12% |
| Tray-Style Freeze Drying | 55% |
| Rotary Freeze Drying | 10% |
| Continuous Freeze Drying | 23% |
The Tray-Style Freeze Drying Segment Led the Lyophilization Equipment and Services Market in 2025
The tray-style freeze-drying segment held a significant share of 55% in the market. Tray-style freeze dryer supports the development of chronic storage vaccines and labile drugs. It performs freeze drying in containers or in ampoules on large quantities. This creates the tray-style freeze dryer become most general for developing lyophilized products. Trays enable huge batch volumes, creating it the preferred technology for accelerating operations from laboratory R&D to commercial-scale healthcare and food processing.
The manifold freeze-drying segment contributed a significant share in the lyophilization equipment and services market of 12%, as manifold freeze-drying is a significantly flexible dehydration technology standard for labs. It enables consumers to dry many distinct samples instantaneously using external valves or flasks. Manifold technology is purchased and is quite satisfactory for the task at hand; it is significant to understand that using a manifold-type freeze dryer has important limitations related to the freeze-drying technology.
The rotary freeze-drying segment held a significant 10% share of the market, as utilizing a gradually rotating drum in a vacuum chamber, rotary freeze dryers offer a continuous, gentle agitation of the product while the drying process. Rapid and gentle drying makes a highly porous structure, enabling advanced solubility and instant reconstitution. Preserves heat-sensitive foods, nutrients, and flavors. It is generally used for ingredients such as herbs, coffee, and powdered dairy.
The continuous freeze drying segment contributed a lyophilization equipment and services market share of 23%, and is expected to grow at the fastest CAGR of the 11.18% during the forecast period, as the freeze-drying technology provides the flexibility to remove moisture content and preserve virtually any fruit and vegetable. Continuous freeze-drying is growing in importance, involving energy saving, high production effectiveness, and greater quality.
| Segment | Share 2025 (%) |
| Pharmaceuticals | 48% |
| Biotechnology | 20% |
| Food Processing | 16% |
| Diagnostics | 8% |
| Research & Academic Institutes | 5% |
| Cosmetics | 3% |
The Pharmaceuticals Segment led the Lyophilization Equipment and Services Market in 2025
The pharmaceuticals segment contributed the largest market share of 48%, as lyophilization equipment has the ability to maintain the stability and functionality of subtle materials. The pharmaceutical industry is especially significant, as major biologic therapeutics need careful handling to retain their effectiveness. Lyophilization enables the manufacture of stable and long-lasting drugs.
The biotechnology segment held a significant share of 20% in the lyophilization Equipment and Services Market and is expected to grow at the fastest CAGR of the 10.76% during the forecast period, as lyophilization helps improve shelf life, protect sensitive ingredients, and support easier storage, shipping, and reconstitution. Lyophilization and homogenization of biological samples improve reproducibility and reduce standard deviation in molecular biology technology.
The food processing segment held a significant share of 16% in the market, as lyophilization efficiently protects bioactive compounds, color, flavor, and rehydration capability in different food technologies, including fruits, vegetables, meats, seafood, and specialty products. Lyophilization is the capability to maintain the stability and functionality of delicate materials, like proteins, enzymes, and other biomolecules.
The diagnostics segment held a significant share of 8% in the market, as lyophilization and homogenization of biological samples enhance reproducibility and reduce standard deviation in molecular biology techniques. It offers flexibility, efficiency, and stability at ambient temperatures. Lyophilization and homogenization of biological samples improve reproducibility and reduce standard deviation in molecular biology techniques.
| Segment | Share 2025 (%) |
| Pharmaceutical Companies | 39% |
| Biotechnology Companies | 18% |
| Contract Development & Manufacturing Organizations (CDMOs) | 17% |
| Food & Beverage Companies | 13% |
| Academic & Research Institutes | 8% |
| Hospitals & Diagnostic Laboratories | 5% |
The Pharmaceutical Companies Segment led the Lyophilization Equipment and Services Market in 2025
The pharmaceutical companies segment contributed the largest market share of 39%, as lyophilization allows stable production of biologics and heat-sensitive injectables while lowering logistics and cold-chain restraints. It plays a significant role in the healthcare industry. This organization has been using freeze-drying technology for many years to extend the shelf life of different medicines.
The biotechnology companies segment held a significant share of 18% in the market, and is expected to grow at the fastest CAGR of 10.81% during the forecast period, as removing moisture, lyophilization potentially improves the stability and preservation of sensitive products, like vaccines, antibiotics, and biopharmaceuticals, enabling them to be stored at room temperature for longer eras deprived of losing their effectiveness.
The contract development & manufacturing organizations (CDMOs) segment held a significant share of 17% in the lyophilization equipment and services market, as lyophilization improves a CDMO’s solutions portfolio by stabilizing temperature-sensitive biologics and increasing product shelf life. It avoids costly cold-chain shipping and enables faster reconstitution
In 2025, North America dominated the lyophilization equipment and services market with 38% share in 2025 because the biopharmaceutical industry of this region has a diverse and interrelated innovation system. The region also executes funding for basic research at academies and national laboratories, along with partnerships in innovative startups & giant pharmaceutical organizations. Pharmaceutical companies are scrambling to onshore drug production, which has strengthened costs for biotech and pharma organizations, contributing to the progression of the market.
US Market Growth
In the U.S., increasing collaboration with a CDMO gives organizations strategic benefits, allowing rapid, scalable, and low-cost drug expansion. There are currently 21,436 food and beverage product producers across the U.S. Many U.S. startups are commercializing groundbreaking microwave heating technologies that significantly speed up the product throughput.
Canada Market Growth
In Canada, the significant focus on healthcare innovation and growing spending in healthcare research bolsters the demand for lyophilization equipment. The Canadian government significantly funds biomedical research and technological initiatives, making an environment where healthcare innovation flourishes. There is an increasing concentration of biopharmaceutical firms and contract development and manufacturing organizations (CDMOs) in Canada.
Asia Pacific held 25% share and is expected to see a rapid growth of 10.54% CAGR in the lyophilization equipment and services market, driven by growing government spending for biotechnology initiatives, attached with private sector investments in R&D. However, India is well-positioned to become an affordable alternative to China for well-developed technology manufacturing, which spurs the overall market expansion.
China Market Growth
In China, growing extensive medical care reforms and favourable conditions have positioned China as a pivotal source of research and product expansion in the biopharmaceutical industry. Chinese major areas such as Beijing and Shanghai have conquered the world in terms of the number of patents filed in the life sciences sector.
India Market Growth
In India, an increasing focus on cancer so rised demand for stable, efficient lyophilization equipment and services. India is increasing in precision engineering, uses automated fill-finish lines, and isolator technology, which confirms zero human contamination. This ability enables Indian manufacturers to produce multifaceted lyophilized cakes at a fraction of the cost.
R&D:
Clinical Trials:
Patient Support & Services:
| Company | Headquarters | Latest Update |
| ATS | Lucknow | Avidity Science is a worldwide water purification company providing systems for laboratory use, with services in the UK, the US, China, and Japan. |
| Azbil | Japan | Azbil Corporation is significantly focused on increasing its worldwide footprint, raising sustainability in its production processes, and combining advanced technology in its automation systems. |
| Buchi | Switzerland | In November 2025, BUCHI launched the Lyovapor L-210, a novel freeze-drying system manufactured for research and development environments. |
| Cuddon | New Zealand | Cuddon units significantly focus on growing capacity, boasting up to 30% more product capacity and limited drying cycles, lowering overall energy usage. |
| GEA Group Aktiengesellschaft | Germany | In July 2025, GEA is spending EUR 80 million on the building of a healthcare technology center for freeze-drying systems in Elsdorf. |
| HOF Sonderanlagenbau | Germany | HOF TECH-Innovation-Day, explore recent advancements, government frameworks, and practical services for a sustainable future in cooling technology for pharmaceutical applications. |
In August 2025, “Working together with Cytiva notably improves our manufacturing capacity, improving the service offered to our customers, especially in the UK/EU marketplace. Putting our customer needs first is at the center of everything we do,” said Stacy Sutton, General Manager of Life Sciences at Argonaut Manufacturing Services, Inc.
By Product Type
By Material
By Technology
By Application
By End User
By Region
Principal Consultant
Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.
Learn more about Shivani Zoting
Reviewed By
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.
Learn more about Aditi Shivarkar
+1 804-441-9344
